Time-dependent diffusion MRI derived microstructure parameters to predict differentiation degree and Ki-67 expression

Fulin Lu1, Kuide Li1, Ran Wu1

  • 1Department of Radiology, Sichuan Provincial People's Hospital, School of medicine, University of Electronic Science and Technology of China, 32# Second Section of First Ring Road, Qingyang District, Chengdu 610072, Sichuan, China.

PubMed
Abstract

Insights

Time-dependent diffusion MRI (td-dMRI) can non-invasively predict rectal cancer differentiation and Ki-67 expression. These microstructural parameters offer valuable insights for treatment decisions.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Rectal cancer grading relies on invasive methods.
  • Accurate prediction of tumor differentiation and Ki-67 expression is crucial for treatment planning.

Purpose of the Study:

  • To evaluate the utility of time-dependent diffusion MRI (td-dMRI) in predicting rectal cancer differentiation and Ki-67 expression.
  • To explore td-dMRI-derived microstructural parameters as non-invasive biomarkers.

Main Methods:

  • Seventy-three rectal cancer patients underwent td-dMRI.
  • Analysis included intracellular volume fraction (ICVF), cellularity, and apparent diffusion coefficient (ADC) at various diffusion times.
  • Statistical methods included logistic regression and ROC analysis to assess diagnostic performance.

Main Results:

  • Cellularity and ADC values were higher in low-differentiation tumors, while ICVF was lower.
  • td-dMRI parameters, including ICVF, cellularity, and ADC, were independent risk factors for differentiation.
  • A combined model achieved an AUC of 0.831 for differentiation.
  • ICVF was lower in high Ki-67 expression tumors.
  • A combined model incorporating clinical factors and ICVF achieved an AUC of 0.820 for predicting high Ki-67 expression.

Conclusions:

  • td-dMRI-derived parameters serve as non-invasive imaging markers for rectal cancer differentiation and Ki-67 expression.
  • These findings can inform treatment decisions for rectal cancer patients.